Arvanitakis, Z., Shah, R. C., & Bennett, D. A. (2019). Diagnosis and management of dementia: Review. JAMA, 322(16), 1589–1599. https://doi.org/10.1001/jama.2019.4782
Article PubMed PubMed Central Google Scholar
Ayodele, T., Rogaeva, E., Kurup, J. T., Beecham, G., & Reitz, C. (2021). Early-onset Alzheimer’s disease: What is missing in research? Current Neurology and Neuroscience Reports, 21(2), 4. https://doi.org/10.1007/s11910-020-01090-y
Article PubMed PubMed Central Google Scholar
Bagyinszky, E., Kang, M. J., Van Giau, V., Shim, K., Pyun, J. M., Suh, J., An, S. S. A., & Kim, S. (2019). Novel amyloid precursor protein mutation, Val669Leu (“Seoul APP”), in a Korean patient with early-onset Alzheimer’s disease. Neurobiology of Aging, 84(231), 236. https://doi.org/10.1016/j.neurobiolaging.2019.08.026
Ben, K. N., Tyteca, D., Marinangeli, C., Depuydt, M., Collet, J. F., Courtoy, P. J., Renauld, J. C., Constantinescu, S., Octave, J. N., & Kienlen-Campard, P. (2012). Structural features of the KPI domain control APP dimerization, trafficking, and processing. FASEB Journal, 26(2), 855–867. https://doi.org/10.1096/fj.11-190207
Bolos, M., Hu, Y., Young, K. M., Foa, L., & Small, D. H. (2014). Neurogenin 2 mediates amyloid-beta precursor protein-stimulated neurogenesis. Journal of Biological Chemistry, 289(45), 31253–31261. https://doi.org/10.1074/jbc.M114.581918
Article CAS PubMed PubMed Central Google Scholar
Chetelat, G., Arbizu, J., Barthel, H., Garibotto, V., Law, I., Morbelli, S., van de Giessen, E., Agosta, F., Barkhof, F., Brooks, D. J., Carrillo, M. C., Dubois, B., Fjell, A. M., Frisoni, G. B., Hansson, O., Herholz, K., Hutton, B. F., Jack, C. R., Lammertsma, A., & Drzezga, A. (2020). Amyloid-PET and (18)F-FDG-PET in the diagnostic investigation of Alzheimer’s disease and other dementias. Lancet Neurology, 19(11), 951–962. https://doi.org/10.1016/S1474-4422(20)30314-8
Article CAS PubMed Google Scholar
Citron, M., Oltersdorf, T., Haass, C., McConlogue, L., Hung, A. Y., Seubert, P., Vigo-Pelfrey, C., Lieberburg, I., & Selkoe, D. J. (1992). Mutation of the beta-amyloid precursor protein in familial Alzheimer’s disease increases beta-protein production. Nature, 360(6405), 672–674. https://doi.org/10.1038/360672a0
Article ADS CAS PubMed Google Scholar
Di Fede, G., Catania, M., Morbin, M., Rossi, G., Suardi, S., Mazzoleni, G., & Tagliavini, F. (2009). A recessive mutation in the APP gene with dominant-negative effect on amyloidogenesis. Science, 323(5920), 1473–1477. https://doi.org/10.1126/science.1168979
Article ADS CAS PubMed PubMed Central Google Scholar
Hansson, O. (2021). Biomarkers for neurodegenerative diseases. Nature Medicine, 27(6), 954–963. https://doi.org/10.1038/s41591-021-01382-x
Article CAS PubMed Google Scholar
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996). Correlative memory deficits, Abeta elevation, and amyloid plaques in transgenic mice. Science, 274(5284), 99–102. https://doi.org/10.1126/science.274.5284.99
Article ADS CAS PubMed Google Scholar
Jack, C. J., Bennett, D. A., Blennow, K., Carrillo, M. C., Dunn, B., Haeberlein, S. B., Holtzman, D. M., Jagust, W., Jessen, F., Karlawish, J., Liu, E., Molinuevo, J. L., Montine, T., Phelps, C., Rankin, K. P., Rowe, C. C., Scheltens, P., Siemers, E., Snyder, H. M., & Sperling, R. (2018). NIA-AA research framework: Toward a biological definition of Alzheimer’s disease. Alzheimer’s Dement., 14(4), 535–562. https://doi.org/10.1016/j.jalz.2018.02.018
Jonsson, T., Atwal, J. K., Steinberg, S., Snaedal, J., Jonsson, P. V., Bjornsson, S., Stefansson, H., Sulem, P., Gudbjartsson, D., Maloney, J., Hoyte, K., Gustafson, A., Liu, Y., Lu, Y., Bhangale, T., Graham, R. R., Huttenlocher, J., Bjornsdottir, G., Andreassen, O. A., & Stefansson, K. (2012). A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline. Nature, 488(7409), 96–99. https://doi.org/10.1038/nature11283
Article ADS CAS PubMed Google Scholar
Kimura, A., Hata, S., & Suzuki, T. (2016). Alternative selection of Beta-site APP-Cleaving Enzyme 1 (BACE1) cleavage sites in Amyloid beta-Protein Precursor (APP) harboring protective and pathogenic mutations within the Abeta Sequence. Journal of Biological Chemistry, 291(46), 24041–24053. https://doi.org/10.1074/jbc.M116.744722
Article CAS PubMed PubMed Central Google Scholar
Knopman, D. S., Amieva, H., Petersen, R. C., Chetelat, G., Holtzman, D. M., Hyman, B. T., Nixon, R. A., & Jones, D. T. (2021). Alzheimer disease. Nature Reviews Disease Primers, 7(1), 33. https://doi.org/10.1038/s41572-021-00269-y
Article PubMed PubMed Central Google Scholar
Lannfelt, L., Viitanen, M., Johanssn, K., & Axelman, K. (1993). Low frequency of the APP670671 mutation in familial Alzheimer’s disease in Sweden. Neuroscience Letters, 153(1993), 85–87.
Article CAS PubMed Google Scholar
Mahalingam, S., & Chen, M. K. (2019). Neuroimaging in dementias. Seminars in Neurology, 39(2), 188–199. https://doi.org/10.1055/s-0039-1678580
Mahaman, Y., Embaye, K. S., Huang, F., Li, L., Zhu, F., Wang, J. Z., Liu, R., Feng, J., & Wang, X. (2022). Biomarkers used in Alzheimer’s disease diagnosis, treatment, and prevention. Ageing Research Reviews, 74, 101544. https://doi.org/10.1016/j.arr.2021.101544
Article CAS PubMed Google Scholar
Mattson, M. P. (2004). Pathways towards and away from Alzheimer’s disease. Nature, 430(7000), 631–639. https://doi.org/10.1038/nature02621
Article ADS CAS PubMed PubMed Central Google Scholar
McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. J., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., Mohs, R. C., Morris, J. C., Rossor, M. N., Scheltens, P., Carrillo, M. C., Thies, P., Weintraub, S., & Phelps, C. H. (2011). The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimer’s & Dementia, 7(3), 263–269. https://doi.org/10.1016/j.jalz.2011.03.005
Migliore, L., & Coppede, F. (2022). Gene-environment interactions in Alzheimer disease: The emerging role of epigenetics. Nature Reviews Neurology, 18(11), 643–660. https://doi.org/10.1038/s41582-022-00714-w
Article CAS PubMed Google Scholar
Milà-Alomà, M., Salvadó, G., Gispert, J. D., Vilor-Tejedor, N., Grau-Rivera, O., Sala-Vila, A., Sánchez-Benavides, G., Arenaza-Urquijo, E. M., Crous-Bou, M., González-de-Echávarri, J. M., Minguillon, C., Fauria, K., Simon, M., Kollmorgen, G., Zetterberg, H., Blennow, K., Suárez-Calvet, M., & Molinuevo, J. L. (2020). Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer’s continuum. Alzheimers Dement, 16(10), 1358–1371. https://doi.org/10.1002/alz.12131
Mullan, M., Crawford, F., Axelman, K., Houlden, H., Lilius, L., Winblad, B., & Lannfelt, L. (1992). A pathogenic mutation for probable Alzheimer’s disease in the APP gene at the N-terminus of beta-amyloid. Nature Genetics, 1(5), 345–347. https://doi.org/10.1038/ng0892-345
Article CAS PubMed Google Scholar
Qin, Q., Yin, Y., Wang, Y., Lu, Y., Tang, Y., & Jia, J. (2020). Gene mutations associated with early onset familial Alzheimer’s disease in China: An overview and current status. Molecular Genetics & Genomic Medicine, 8(10), e1443. https://doi.org/10.1002/mgg3.1443
Scheltens, P., De Strooper, B., Kivipelto, M., Holstege, H., Chételat, G., Teunissen, C. E., Cummings, J., & van der Flier, W. M. (2021). Alzheimer’s disease. Lancet, 397(10284), 1577–1590. https://doi.org/10.1016/S0140-6736(20)32205-4
Article CAS PubMed PubMed Central Google Scholar
Tiwari, S., Atluri, V., Kaushik, A., Yndart, A., & Nair, M. (2019). Alzheimer’s disease: Pathogenesis, diagnostics, and therapeutics. International Journal of Nanomedicine, 14(5541), 5554. https://doi.org/10.2147/IJN.S200490
Valotassiou, V., Malamitsi, J., Papatriantafyllou, J., Dardiotis, E., Tsougos, I., Psimadas, D., Alexiou, S., Hadjigeorgiou, G., & Georgoulias, P. (2018). SPECT and PET imaging in Alzheimer’s disease. Annals of Nuclear Medicine, 32(9), 583–593. https://doi.org/10.1007/s12149-018-1292-6
留言 (0)